Segmentation by type classifies hair growth serums into four subcategories: Minoxidil‑based, Peptide‑enhanced, Botanical‑extract, and Hormone‑regulating formulations. Minoxidil‑based serums, occupying the largest share (approximately 45 %), rely on a well‑documented vasodilatory mechanism that extends the anagen phase of hair follicles. Peptide‑enhanced products, about 25 % of the market, incorporate bioactive sequences such as copper‑tripeptide‑1 to promote cellular proliferation and extracellular matrix remodeling. Botanical‑extract serums, representing 20 %, leverage compounds like saw palmetto, caffeine, and rosemary oil, emphasizing safety and natural‑origin claims that appeal to risk‑averse consumers. Hormone‑regulating serums, the smallest segment at 10 %, contain ingredients such as finasteride analogues or estrogen‑modulating phytochemicals targeting hormonal pathways implicated in alopecia. The relative size of each type reflects regulatory constraints, clinical efficacy data, and consumer perception of safety versus performance, collectively shaping the market’s product‑mix dynamics.